Deflectable Transducers for Accurate Dose Detection in Drug Injection Devices
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Disposable pen injection devices lack reliable electronic features due to high production costs, leading to errors in dose detection and administration, particularly from accidental activations during handling or transportation.
Innovation Solution
A drug injection device with a pair of deflectable transducers and a processor that registers activation signals from protrusions, using a time delay between signals to differentiate between intended and unintended activations, thereby reducing errors and enabling cost-effective production with integrated electronic components on a flexible sheet.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If electronic components are integrated into disposable injection devices, then measurement precision and reliability of dose detection are improved, but manufacturing cost increases
Solution Approach 1:
The patent applies the disposable principle by designing the entire injection device including electronic components (transducers, processor, memory) as a single-use unit. The electronic components are integrated into a disposable cartridge that is discarded after one use, eliminating the need for expensive reusable electronic components. This resolves the contradiction by making the device economically viable for single-use applications while maintaining accurate dose detection capabilities through integrated electronics.
Solution Approach 2:
The patent changes the operational parameters of the transducers by using deflectable elements that respond to mechanical movement during injection. The transducers are configured to detect specific movement patterns (deflection distances, time delays between activations) that correspond to legitimate dose administration. This parameter-based detection approach enables accurate dose measurement while using simple, cost-effective transducer designs suitable for disposable devices.
2Ease of operation
If switch structures are used for input means, then ease of operation is improved, but reliability deteriorates due to erroneous activations during handling or transportation
Solution Approach 1:
The patent applies preliminary action by configuring the transducer system to expect and recognize specific sequences of activations corresponding to legitimate injection operations. The processor is programmed with predetermined patterns (e.g., specific time delays between transducer activations, specific sequences of protrusion engagements) that must be matched before registering a dose. This preliminary programming enables the system to distinguish between intentional user actions and accidental activations during handling or transportation.
Solution Approach 2:
The patent implements feedback through the processor's analysis of transducer activation patterns. The system continuously monitors the sequence, timing, and pattern of transducer responses, comparing them against predetermined criteria for legitimate injection operations. When the activation pattern matches the expected sequence (e.g., correct time delay between first and second transducer activations), the system registers the dose; when it doesn't match (e.g., simultaneous activation indicating a drop), the system rejects it as erroneous. This feedback mechanism maintains ease of operation while eliminating false activations.
3Reliability
If multiple deflectable transducers are used to detect activation sequences, then reliability is improved by reducing erroneous detections, but device complexity increases
Solution Approach 1:
The patent applies segmentation by dividing the detection function into multiple independent deflectable transducers positioned at different locations along the injection path. Each transducer responds to specific mechanical events (e.g., piston movement, needle advancement) at different stages of the injection process. This segmentation enables the system to detect the sequence of operations and verify that they occur in the correct order with appropriate time delays, significantly improving reliability while keeping each individual transducer simple in design.
Solution Approach 2:
The patent utilizes periodic action by designing the transducer system to detect repetitive mechanical events that occur during normal injection operation. The deflectable transducers are positioned to respond to periodic movements of injection components (piston reciprocation, needle advancement increments) that follow a predictable pattern. The processor analyzes these periodic signals to confirm legitimate operation, distinguishing them from random activations caused by accidental drops or handling errors. This periodic detection approach improves reliability without requiring complex transducer designs.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The device reliably detects and records drug doses with reduced error rates, including accidental activations, while allowing for inexpensive manufacturing through the use of printed electronic components on a flexible substrate.
Implementation Method 1
a first element (140) and a second element (103) arranged co-axially along a central axis, the first element and/or the second element being rotationally movable around the central axis... the second element comprises first and second deflectable transducers, each of the first and the second deflectable transducer being configured for sequentially cooperating with the plurality of protrusions of the first element to become deflected thereby generating an activation signal
Data Source
Figure 1
Figure 2
Figure 3A~3B
AI summary
The present invention provides a drug injection device (100) comprising a first element (140) and a second element (103) configured to undergo unidirectional movement relative to each other corresponding to an action performed on or by the drug injection device (100), wherein the first element (140) comprises a plurality of serially disposed protrusions (143), wherein the second element (103) comprises first and second deflectable transducers (103a/153a, 103b/153b) configured for sequentially cooperating with the plurality of protrusions (143), and wherein a processor (151) is electrically connected with the first and second deflectable transducers (103a/153a, 103b/153b) to register activation signals, wherein the protrusion configuration is so disposed on the first element (140) and the first and second deflectable transducers (103a/153a, 103b/153b) are so disposed on the second element (103) that a second activation signal generated by the second deflectable transducer (103b/153b) is delayed relative to a first activation signal generated by the first deflectable transducer (103a/153a) as the first element (140) and the second element (103) move relative to each other, and wherein the processor (151) is configured to provide a) a first control action if a time delay between the first and second activation signals is above or equal to a pre-defined value, and b) a second control action if said time delay is below said pre-defined value.